ANA380

ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants

...ensitivity to ANA380's antiviral effects in vitro. ana380 was active against the HBV mutant resistant to tel...s the promising spectrum of antiviral activity for ana380 against a defined panel of genetically defined dru...ith previously reported clinical data showing that ana380 is active in patients refractory to lamivudine." ...

Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection

...development of ANA975 will be able to be resumed. There also is no guarantee regarding Anadys' future involvement with, or value recognition from, the ana380 program. Anadys' results may be further affected by risks related to its collaborative relationships with Novartis and LG Life Sciences, competition f...

ANA380 in other areas

Relevant Hepatitis B Virus Mutants

ANA380 Exhibits Activity In Vitro Against Multiple Clinically ... ANA380 was active against the HBV mutant resistant to telbivudine in prior clinical studies. ...

Patients

ANA380 was safe and well-tolerated in this study, and there were no serious ... "We are delighted by ANA380's promising clinical results and believe that these ...

Anadys Pharmaceuticals, Inc. Release: Robust Viral Load Reduction ...

ANA380 was safe and well-tolerated in this study, and there were no serious ... "We are delighted by ANA380's promising clinical results and believe that these ...

Phase II Multi-Center, Dose-Escalating study of LB80380 (ANA380) in ...

... from a Phase 2 dosing study of ANA380 at the 41st EASL conference in Vienna, Austria. ... ANA380 (LB80380) is an ester drug of phosphonate nucleotide analogue of ...

News Review

About ANA380 (LB80380) ANA380 (LB80380) is an oral prodrug of ANA317 (LB80317) ... Anadys and LG Life Sciences are jointly developing ANA380 on a global basis. ...